Neurocrine Biosciences, Inc.
DE ˙ DB ˙ US64125C1099
134,65 € ↑0,30 (0,22%)
2026-06-03
DEL PRIS
SecurityDE:NB3 / Neurocrine Biosciences, Inc.
InstitutionCaption Management, LLC
Latest Disclosed Ownership8,900 shares
Latest Disclosed Value $ 1,172,486
Caption Management, LLC ownership in NB3 / Neurocrine Biosciences, Inc.

On May 15, 2026 - Caption Management, LLC filed a 13F-HR form disclosing ownership of 8,900 shares of Neurocrine Biosciences, Inc. (DE:NB3) valued at $994,575 USD as of March 31, 2026. The entity filed a previous 13F-HR on August 14, 2025 disclosing 0 shares of Neurocrine Biosciences, Inc.. The current value of the position is $1,198,385 USD.

Caption Management, LLC has a history of taking positions in derivatives of the underlying security (NB3) in the form of stock options. The firm currently holds call options representing 30,000 of underlying shares valued at $3,952,200 USD and put options representing 30,000 of underlying shares valued at $3,952,200 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:NB3 / Neurocrine Biosciences, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 8,900 8,900 1,172 0.0068
2025-08-14 2025-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -130,800 -100.00 0 -100.00
2025-05-15 2025-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 130,800 130,800 14,466 0.1391
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -2,900 -100.00 0 -100.00
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,900 -45,700 -94.03 334 -95.01 0.0053
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 48,600 28,400 140.59 6,691 140.22 0.1030
2024-05-15 2024-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 20,200 20,200 2,786 0.0423
2023-11-14 2023-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -9,000 -100.00 0 -100.00
2023-08-14 2023-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 9,000 9,000 849 0.0150
2022-08-15 2022-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -21,000 -100.00 0 -100.00
2022-05-13 2022-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 21,000 8,762 71.60 1,968 88.69 0.0237
2022-02-11 2021-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 12,238 -11,594 -48.65 1,043 -54.37 0.0117
2021-11-12 2021-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 23,832 21,260 826.59 2,286 814.40 0.0261
2021-08-16 2021-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 2,572 -4,037 -61.08 250 -61.12 0.0033
2021-05-17 2021-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 6,609 -9,391 -58.69 643 -58.08 0.0138
2021-02-16 2020-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 16,000 -4,900 -23.44 1,534 -23.68 0.0350
2020-11-16 2020-09-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 20,900 -28,989 -58.11 2,010 -66.97 0.0470
2020-08-14 2020-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 49,889 10,989 28.25 6,086 80.81 0.2027
2020-05-15 2020-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 38,900 23,700 155.92 3,366 106.12 0.1904
2020-02-13 2019-12-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 15,200 15,200 -60.93 1,633 -51.49 0.0549
2019-08-13 2019-06-30 13F NEUROCRINE BIOSCIENCES COM 64125C109 0 -25,000 -100.00 0 -100.00
2019-05-14 2019-03-31 13F NEUROCRINE BIOSCIENCES COM 64125C109 25,000 25,000 2,203 0.1214
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F NEUROCRINE BIOSCIENCES COM Call 30,000 -14.29 3,952 -20.39 n/a n/a n/a
2026-02-17 2025-12-31 13F NEUROCRINE BIOSCIENCES COM Call 35,000 16.67 4,964 17.88 n/a n/a n/a
2025-11-14 2025-09-30 13F NEUROCRINE BIOSCIENCES COM Call 30,000 0.00 4,211 11.70 n/a n/a n/a
2025-08-14 2025-06-30 13F NEUROCRINE BIOSCIENCES COM Call 30,000 3,771 n/a n/a n/a
2025-02-14 2024-12-31 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-11-14 2024-09-30 13F NEUROCRINE BIOSCIENCES COM Call 40,100 167.33 4,620 123.73 n/a n/a n/a
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM Call 15,000 2,065 n/a n/a n/a
2024-05-15 2024-03-31 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES COM Call 55,000 -8.33 7,247 7.35 n/a n/a n/a
2023-11-14 2023-09-30 13F NEUROCRINE BIOSCIENCES COM Call 60,000 33.33 6,750 59.09 n/a n/a n/a
2023-08-14 2023-06-30 13F NEUROCRINE BIOSCIENCES COM Call 45,000 50.00 4,244 39.76 n/a n/a n/a
2023-05-15 2023-03-31 13F NEUROCRINE BIOSCIENCES COM Call 30,000 20.00 3,037 1.67 n/a n/a n/a
2023-02-14 2022-12-31 13F NEUROCRINE BIOSCIENCES COM Call 25,000 -12.59 2,986 -1.71 n/a n/a n/a
2022-11-14 2022-09-30 13F NEUROCRINE BIOSCIENCES COM Call 28,600 -48.00 3,038 -43.33 n/a n/a n/a
2022-08-15 2022-06-30 13F NEUROCRINE BIOSCIENCES COM Call 55,000 -38.89 5,361 -36.48 n/a n/a n/a
2022-05-13 2022-03-31 13F NEUROCRINE BIOSCIENCES COM Call 90,000 -18.18 8,440 -9.93 n/a n/a n/a
2022-02-11 2021-12-31 13F NEUROCRINE BIOSCIENCES COM Call 110,000 22.22 9,371 8.56 n/a n/a n/a
2021-11-12 2021-09-30 13F NEUROCRINE BIOSCIENCES COM Call 90,000 50.00 8,632 47.91 n/a n/a n/a
2021-08-16 2021-06-30 13F NEUROCRINE BIOSCIENCES COM Call 60,000 5,836 n/a n/a n/a
2021-02-16 2020-12-31 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2020-11-16 2020-09-30 13F NEUROCRINE BIOSCIENCES COM Call 30,000 0.00 2,886 -21.15 n/a n/a n/a
2020-08-14 2020-06-30 13F NEUROCRINE BIOSCIENCES COM Call 30,000 -57.14 3,660 -39.58 n/a n/a n/a
2020-05-15 2020-03-31 13F NEUROCRINE BIOSCIENCES COM Call 70,000 180.00 6,058 125.46 n/a n/a n/a
2020-02-13 2019-12-31 13F NEUROCRINE BIOSCIENCES COM Call 25,000 -64.29 2,687 -55.65 n/a n/a n/a
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-13 2019-06-30 13F NEUROCRINE BIOSCIENCES COM Call 30,000 33.33 2,534 27.85 n/a n/a n/a
2019-05-14 2019-03-31 13F NEUROCRINE BIOSCIENCES COM Call 22,500 1,982 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F NEUROCRINE BIOSCIENCES COM Put 30,000 3,952 n/a n/a n/a
2026-02-17 2025-12-31 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2025-11-14 2025-09-30 13F NEUROCRINE BIOSCIENCES COM Put 53,000 32.50 7,440 48.00 n/a n/a n/a
2025-08-14 2025-06-30 13F NEUROCRINE BIOSCIENCES COM Put 40,000 -73.39 5,028 -69.76 n/a n/a n/a
2025-05-15 2025-03-31 13F NEUROCRINE BIOSCIENCES COM Put 150,300 16,623 n/a n/a n/a
2024-08-14 2024-06-30 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2024-05-15 2024-03-31 13F NEUROCRINE BIOSCIENCES COM Put 25,000 -54.46 3,448 -52.33 n/a n/a n/a
2024-02-14 2023-12-31 13F NEUROCRINE BIOSCIENCES COM Put 54,900 68.92 7,234 97.84 n/a n/a n/a
2023-11-14 2023-09-30 13F NEUROCRINE BIOSCIENCES COM Put 32,500 8.33 3,656 29.23 n/a n/a n/a
2023-08-14 2023-06-30 13F NEUROCRINE BIOSCIENCES COM Put 30,000 0.00 2,829 -6.82 n/a n/a n/a
2023-05-15 2023-03-31 13F NEUROCRINE BIOSCIENCES COM Put 30,000 50.00 3,037 27.14 n/a n/a n/a
2023-02-14 2022-12-31 13F NEUROCRINE BIOSCIENCES COM Put 20,000 2,389 n/a n/a n/a
2022-11-14 2022-09-30 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2022-08-15 2022-06-30 13F NEUROCRINE BIOSCIENCES COM Put 55,000 -60.71 5,361 -59.16 n/a n/a n/a
2022-05-13 2022-03-31 13F NEUROCRINE BIOSCIENCES COM Put 140,000 133.33 13,128 156.81 n/a n/a n/a
2022-02-11 2021-12-31 13F NEUROCRINE BIOSCIENCES COM Put 60,000 -33.33 5,112 -40.78 n/a n/a n/a
2021-11-12 2021-09-30 13F NEUROCRINE BIOSCIENCES COM Put 90,000 50.00 8,632 47.91 n/a n/a n/a
2021-08-16 2021-06-30 13F NEUROCRINE BIOSCIENCES COM Put 60,000 5,836 n/a n/a n/a
2021-05-17 2021-03-31 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-02-16 2020-12-31 13F NEUROCRINE BIOSCIENCES COM Put 80,000 15.94 7,669 15.57 n/a n/a n/a
2020-11-16 2020-09-30 13F NEUROCRINE BIOSCIENCES COM Put 69,000 130.00 6,636 81.31 n/a n/a n/a
2020-08-14 2020-06-30 13F NEUROCRINE BIOSCIENCES COM Put 30,000 0.00 3,660 40.99 n/a n/a n/a
2020-05-15 2020-03-31 13F NEUROCRINE BIOSCIENCES COM Put 30,000 20.00 2,596 -3.39 n/a n/a n/a
2020-02-13 2019-12-31 13F NEUROCRINE BIOSCIENCES COM Put 25,000 -16.67 2,687 3.51 n/a n/a n/a
2019-11-14 2019-09-30 13F NEUROCRINE BIOSCIENCES COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2019-08-13 2019-06-30 13F NEUROCRINE BIOSCIENCES COM Put 30,000 -64.71 2,534 -66.16 n/a n/a n/a
2019-05-14 2019-03-31 13F NEUROCRINE BIOSCIENCES COM Put 85,000 7,488 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.